Jeff Berkowitz - CEO Real Endpoints Inc.

Jeff is a leader in providing insights, support and tools to strengthen access to pharmaceutical innovation for an evolving healthcare landscape with a concentrated focus on value based arrangements, patient services and market access support for pharmaceutical manufacturers and payors. 

Catherine Pickering - CEO of iOnctura

Roel Bulthuis - Managing Partner and Head of Investments of Syncona Investment Management Ltd

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Aoife Brennan - ex-CEO Synlogic Therapeutics

Dr. Aoife Brennan, M.B. Ch.B., is an accomplished biotechnology leader with over 20 years of experience leading drug development organizations across a range of stages and therapeutic areas.

Nathan Furr - Professor of Innovation and Strategy at INSEAD

Nathan earned his PhD from the Stanford Technology Ventures Program at Stanford University and holds BA, MA and MBA degrees from Brigham Young University. He has held permanent or visiting positions at INSEAD, ESSEC, and BYU.

Ted Love - Chair of the Board of Directors at the Biotechnology Innovation Organization (BIO)

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

We are offering a CEO reTREAT on the Tuesday of the Jeffries Conference.

Eliot Forster - CEO at Levicept

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

Jean-Christophe Tellier - Chief Executive Officer at UCB

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

François Candelon & Leonid Zhukov - BCG Henderson Institute

François Candelon is currently a Partner at Seven2, a French private equity firm. Previously, he served as the Global Director of the BCG Henderson Institute (2019-2024).

Leonid Zhukov is the Director of the BCG Global AI Institute, where he plays a pivotal role in exploring how artificial intelligence, particularly generative AI (GenAI), can transform industries.

Ted Love - Chair of the Board of Directors at the Biotechnology Innovation Organization (BIO)

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

Arnaud Chevallier - Professor of Strategy at IMD

At IMD, Arnaud is the Director of the Global Management Foundations program, which is a core component of the executive MBA, the master of science in sustainable management and technology offered jointly with EPFL and the Université de Lausanne, and various other IMD programs.

Edwin Moses - Chairman of Achilles Therapeutics (UK), Avantium NV (Netherlands), LabGenius Ltd (UK)

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

Claudia Ulbrich - CEO at Cardior Pharmaceuticals GmbH

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

David Dye - President at Let’s Grow Leaders

David is President of Let’s Grow Leaders, a global leadership development firm known for practical tools and techniques for human-centered leaders.

Dr. Randall Peterson - Senior Director of the Leadership Institute of the London Business School

Dr. JoEllyn Prouty McLaren - CEO & CLO at TalentSage

Cyril Peupion - Team Well-Being and Productivity Expert & Author

Cyril is a thought leader in the areas of productivity, time management and work life balance. As one of the world’s leading experts on productivity, Cyril supports executives, leaders and teams to improve performance & work life balance by changing work habits.

Ray Barlow - CEO at SynOx Therapeutics

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Dr. Elaine V. Jones - NED and Board Chair

Dr. Jones currently serves on the boards of the publicly traded companies CytomX (NASDAQ: CTMX), HBM Healthcare Investments AG (SIX: HBMN), and NextCure (NASDAQ: NXTC), and is the Chair of Gritstone bio (NASDAQ: GRTS). In addition, Dr. Jones is Chair of Mironid, a privately held UK company (Edinburgh, Scotland) focused on new treatments for degenerative kidney disease, and serves as a Director of Myeloid Therapeutics (Cambridge, MA), a private company developing products to reprogram myeloid cells for cancer therapy. She also serves on the advisory board of the Novartis Venture Fund and as a member of the Cancer Prevention and Research Institute of Texas (CPRIT) Product Development Review Council.

Brandon Fenn - Partner (New York) and Tom Goodman - Partner (London)

This is our first Cooley Office Hour, where Tom Goodman from the London office and Brandon Fenn from their NY office will discuss the current landscape of deals in financing, partnering and M&A.

Bruce Booth - Partner at Atlas Venture

Bruce is currently chairman of Arkuda Therapeutics, AvroBio (NASDAQ:AVRO), Hotspot Therapeutics, Kymera Therapeutics (NASDAQ:KYMR), Matchpoint Therapeutics, Nimbus Therapeutics, and Vigil Neuroscience (NASDAQ: VIGL). He also serves on the boards of Lifordi and Sionna Therapeutics, and several seed stage companies. He previously served on the boards of past Atlas companies Avila (acquired by Celgene), Lysosomal Therapeutics (acquired by Bial), Padlock (acquired by BMS), Prestwick (acquired by Biovail), Rodin Therapeutics (acquired by Alkermes), Stromedix (acquired by Biogen), and a number of other ventures.

Tim Dyer - Co-Founder, Director and CEO of Addex Therapeutics and Neurosterix

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Shaun Foy & Rodger Novak - Co-Founders at CRISPR Therapeutics

Rodger and Shaun co-founded CRISPR Therapeutics in Switzerland in 2013 with Nobel Prize Laureate Emmanuelle Charpentier but pivoted the company’s footprint towards the U.S. very early on and with good reason, including an IPO on NASDAQ in 2016.

Detlev Biniszkiewicz - Managing Director at MPM BioImpact

Detlev is a serial entrepreneur and an experienced biopharma executive who brings deep knowledge of oncology and immuno-oncology to his role; recently, Detlev served as CEO of portfolio company NextPoint Therapeutics.

Eva Lotta-Allan - Independent Director

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 8 Members. 

Bobby Gaspar - CEO at Orchard Therapeutics

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Dr. Ted Love - Chair of the Board of Directors at the Biotechnology Innovation Organization (BIO)

Dr. Love currently serves on the boards of directors of Royalty Pharma and Seagen. Dr. Love holds a B.A. in molecular biology from Haverford College and an M.D. from Yale Medical School. He completed a residency in internal medicine and a fellowship in cardiology at the Massachusetts General Hospital.

Maximilien Levesque - CEO at AQEMIA

MASTERMIND is an opportunity for informal CEO peer-to-peer conversations. Each MASTERMIND is anchored by a member willing to share and discuss a particular experience / expertise.

Scott Chambers - Managing Partner at Caerus Change

Scott is a leading expert in psychological safety with decades of experience as a trainer, facilitator and coach.

Jan van de Winkel - CEO Genmab

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 5 - 6 Members. 

Sheila Gujrathi - Chair Ventyx BioSciences

CEO Clinics are an intimate forum for confidential exchange on a given topic and therefore limited to 5 - 6 Members.